MetabolicGLP Launches Clinical Research Hub & Interactive HOMA-IR CalculatorNew open-access platform provides evidence-based analysis on endogenous GLP-1 secretion, Akkermansia muciniphila gut dynamics, and cellular AMPK activation.
As clinical interest in glucagon-like peptide-1 (GLP-1) pathways expands, MetabolicGLP bridges the gap between complex peer-reviewed literature and actionable, evidence-based nutritional protocols. The platform compiles double-blind clinical trials examining how the gut microbiome and targeted bio-compounds modulate endogenous incretin hormone exocytosis. A core feature of the launch is the interactive HOMA-IR Calculator (Homeostatic Model Assessment of Insulin Resistance). Designed for clinicians and health-conscious individuals, the tool offers immediate, evidence-based reference intervals utilizing fasting glucose and fasting insulin metrics to evaluate subclinical metabolic resistance. "Our editorial commitment at MetabolicGLP is to deliver transparent, PubMed-referenced evaluations of metabolic signaling pathways," stated Dr. Julian Vance, PhD, Lead Metabolic Researcher for the platform. "Emerging data on gut mucosal regulators like Akkermansia muciniphila and cellular AMPK activators such as high-bioavailability Berberine phytosome highlight viable non-pharmaceutical approaches to glycemic homeostasis." The research portal features comprehensive clinical guides analyzing the P9 protein pathway, Short-Chain Fatty Acid (SCFA) production, and an evidence-based 7-Day Metabolic Reset framework. To access the clinical research reviews and free interactive health tools, visit https://metabolicglp.com End
|
|
Account Phone Number